Back to Search Start Over

Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen (68Ga-PSMA) positron-emission/computed tomography after radical prostatectomy with pathological node-positive extended lymph node dissection

Authors :
Huits, T.H. (Thijs H.)
Luiting, H.B. (Henk B.)
Poel, H.G. (Henk) van der
Nandurkar, R. (Rohan)
Donswijk, M. (Maarten)
Schaake, E.E. (Eva)
Vogel, W.V. (Wouter)
Roobol-Bouts, M.J. (Monique)
Wit, E. (Esther)
Stricker, P.D. (Phillip D.)
Emmett, L. (Louise)
Leeuwen, P.J. (Pim) van
Huits, T.H. (Thijs H.)
Luiting, H.B. (Henk B.)
Poel, H.G. (Henk) van der
Nandurkar, R. (Rohan)
Donswijk, M. (Maarten)
Schaake, E.E. (Eva)
Vogel, W.V. (Wouter)
Roobol-Bouts, M.J. (Monique)
Wit, E. (Esther)
Stricker, P.D. (Phillip D.)
Emmett, L. (Louise)
Leeuwen, P.J. (Pim) van
Publication Year :
2020

Abstract

Objectives: To examine the anatomical distribution of prostate cancer (PCa) recurrence on gallium-68 prostate-specific membrane antigen (68Ga-PSMA) positron-emission tomography (PET)/computed tomography (CT) in patients with biochemical recurrence (BCR) after undergoing radical prostatectomy (RP) with pathological lymph node metastasis (pN1) in their extended pelvic lymph node dissection (ePLND), and to compare the location of PCa recurrence with the location of the initial lymph node metastasis at ePLND. Materials and Methods: We retrospectively reviewed 100 patients with BCR (PSA 0.05–5.00 ng/mL) after RP with pN1 ePLND who underwent 68Ga-PSMA PET/CT to guide salvage therapy. Clinical and pathological features and anatomical locations of PCa recurrence on 68Ga-PSMA PET/CT were obtained, and management

Details

Database :
OAIster
Notes :
application/pdf, BJU International, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1157012772
Document Type :
Electronic Resource
Full Text :
https://doi.org/10.1111.bju.15052